Engineered self-assembling monolayers for label free detection of influenza nucleoprotein

Verfasser / Beitragende:
[Anton Le Brun, Andrei Soliakov, Deepan Shah, Stephen Holt, Alison McGill, Jeremy Lakey]
Ort, Verlag, Jahr:
2015
Enthalten in:
Biomedical Microdevices, 17/3(2015-06-01), 1-10
Format:
Artikel (online)
ID: 605479828
LEADER caa a22 4500
001 605479828
003 CHVBK
005 20210128100412.0
007 cr unu---uuuuu
008 210128e20150601xx s 000 0 eng
024 7 0 |a 10.1007/s10544-015-9951-z  |2 doi 
035 |a (NATIONALLICENCE)springer-10.1007/s10544-015-9951-z 
245 0 0 |a Engineered self-assembling monolayers for label free detection of influenza nucleoprotein  |h [Elektronische Daten]  |c [Anton Le Brun, Andrei Soliakov, Deepan Shah, Stephen Holt, Alison McGill, Jeremy Lakey] 
520 3 |a Integrating nanotechnology into useable devices requires a combination of bottom up and top down methodology. Often the techniques to measure and control these different components are entirely different, so methods that can analyse the nanoscale component in situ are of increasing importance. Here we describe a strategy that employs a self-assembling monolayer of engineered protein chimeras to display an array of oriented antibodies (IgG) on a microelectronic device for the label free detection of influenza nucleoprotein. The structural and functional properties of the bio-interface were characterised by a range of physical techniques including surface plasmon resonance, quartz-crystal microbalance and neutron reflectometry. This combination of methods reveals a 13.5nm thick engineered-monolayer that (i) self-assembles on gold surfaces, (ii) captures IgG with high affinity in a defined orientation and (iii) specifically recognises the influenza A nucleoprotein. Furthermore we also show that this non-covalent self-assembled structure can render the dissociation of bound IgG irreversible by chemical crosslinking in situ without affecting the IgG function. The methods can thus describe in detail the transition from soluble engineered molecules with nanometre dimensions to an array that demonstrates the principles of a working influenza sensor. 
540 |a The Author(s), 2015 
690 7 |a Protein engineering  |2 nationallicence 
690 7 |a Surface plasmon resonance  |2 nationallicence 
690 7 |a Quartz-crystal microbalance  |2 nationallicence 
690 7 |a Neutron reflectometry  |2 nationallicence 
690 7 |a Self-assembled monolayer  |2 nationallicence 
690 7 |a Influenza  |2 nationallicence 
690 7 |a BS(PEG)5 : Bis(succinimidyl) penta(ethylene glycol)  |2 nationallicence 
690 7 |a BSSS : Bis(sulfosuccinimidyl) suberate  |2 nationallicence 
690 7 |a ctOmpA : Circularly permuted transmembrane domain of E. coli outer membrane protein A  |2 nationallicence 
690 7 |a GGZctOmpA : N-terminal tandem pair of B domains from protein G with a C-terminal ctOmpA scaffold  |2 nationallicence 
690 7 |a IgG : Immunoglobulin G  |2 nationallicence 
690 7 |a mAb245 : Mouse monoclonal IgG raised against rNP  |2 nationallicence 
690 7 |a mAb108 : Mouse monoclonal IgG raised against rNP (different epitope to mAb245)  |2 nationallicence 
690 7 |a NP : Native nucleoprotein from influenza  |2 nationallicence 
690 7 |a NR : Neutron reflectometry  |2 nationallicence 
690 7 |a nSLD : Neutron scattering length density  |2 nationallicence 
690 7 |a PBS : Phosphate buffered saline  |2 nationallicence 
690 7 |a QCM-D : Quartz-crystal microbalance with dissipation monitoring  |2 nationallicence 
690 7 |a rNP : Recombinant nucleoprotein  |2 nationallicence 
690 7 |a SPR : Surface plasmon resonance  |2 nationallicence 
690 7 |a thioPEG : 1-mercaptoundec-11-yltriethylene glycol  |2 nationallicence 
700 1 |a Le Brun  |D Anton  |u Bragg Institute, Australian Nuclear Science and Technology Organisation, Locked Bag 2001, 2232, Kirrawee DC, NSW, Australia  |4 aut 
700 1 |a Soliakov  |D Andrei  |u Institute for Cell and Molecular Biosciences, The Medical School, Newcastle University, Framlington Place, NE2 4HH, Newcastle upon Tyne, UK  |4 aut 
700 1 |a Shah  |D Deepan  |u Orla Protein Technologies Ltd, Biosciences Centre, International Centre for Life, Times Square, NE1 4EP, Newcastle upon Tyne, UK  |4 aut 
700 1 |a Holt  |D Stephen  |u Bragg Institute, Australian Nuclear Science and Technology Organisation, Locked Bag 2001, 2232, Kirrawee DC, NSW, Australia  |4 aut 
700 1 |a McGill  |D Alison  |u Institute for Cell and Molecular Biosciences, The Medical School, Newcastle University, Framlington Place, NE2 4HH, Newcastle upon Tyne, UK  |4 aut 
700 1 |a Lakey  |D Jeremy  |u Institute for Cell and Molecular Biosciences, The Medical School, Newcastle University, Framlington Place, NE2 4HH, Newcastle upon Tyne, UK  |4 aut 
773 0 |t Biomedical Microdevices  |d Springer US; http://www.springer-ny.com  |g 17/3(2015-06-01), 1-10  |x 1387-2176  |q 17:3<1  |1 2015  |2 17  |o 10544 
856 4 0 |u https://doi.org/10.1007/s10544-015-9951-z  |q text/html  |z Onlinezugriff via DOI 
898 |a BK010053  |b XK010053  |c XK010000 
900 7 |a Metadata rights reserved  |b Springer special CC-BY-NC licence  |2 nationallicence 
908 |D 1  |a research-article  |2 jats 
949 |B NATIONALLICENCE  |F NATIONALLICENCE  |b NL-springer 
950 |B NATIONALLICENCE  |P 856  |E 40  |u https://doi.org/10.1007/s10544-015-9951-z  |q text/html  |z Onlinezugriff via DOI 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Le Brun  |D Anton  |u Bragg Institute, Australian Nuclear Science and Technology Organisation, Locked Bag 2001, 2232, Kirrawee DC, NSW, Australia  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Soliakov  |D Andrei  |u Institute for Cell and Molecular Biosciences, The Medical School, Newcastle University, Framlington Place, NE2 4HH, Newcastle upon Tyne, UK  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Shah  |D Deepan  |u Orla Protein Technologies Ltd, Biosciences Centre, International Centre for Life, Times Square, NE1 4EP, Newcastle upon Tyne, UK  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Holt  |D Stephen  |u Bragg Institute, Australian Nuclear Science and Technology Organisation, Locked Bag 2001, 2232, Kirrawee DC, NSW, Australia  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a McGill  |D Alison  |u Institute for Cell and Molecular Biosciences, The Medical School, Newcastle University, Framlington Place, NE2 4HH, Newcastle upon Tyne, UK  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Lakey  |D Jeremy  |u Institute for Cell and Molecular Biosciences, The Medical School, Newcastle University, Framlington Place, NE2 4HH, Newcastle upon Tyne, UK  |4 aut 
950 |B NATIONALLICENCE  |P 773  |E 0-  |t Biomedical Microdevices  |d Springer US; http://www.springer-ny.com  |g 17/3(2015-06-01), 1-10  |x 1387-2176  |q 17:3<1  |1 2015  |2 17  |o 10544